.avif)
Total amount raised
$179 Million
Latest funding date
2026-09-01
Location
Ultrahuman has raised funding over seven rounds, with the latest being a Series C round of about $60 million led by Qualcomm Ventures in September 2026 at a post-money valuation of roughly $363 million. The company is backed by investors including Alpha Wave, Blume Ventures, Nexus Venture Partners, Steadview Capital, and Alteria Capital.
What Is Ultrahuman?
Ultrahuman, founded in 2019, is a health and fitness technology company based in Bangalore, Karnataka, India. The company operates in multiple industries, including biotechnology, clinical trials, fitness, health care, and wellness.
Ultrahuman offers a range of products designed to track and enhance various aspects of health. Their offerings include advanced wearable devices like the Ultrahuman Ring AIR, blood testing services through Blood Vision, and continuous glucose monitoring with the M1 CGM sensor.
How Much Funding Has Ultrahuman Raised?
- Seed Round
- Amount Raised: USD 7,500,000
- Date: 2019
- Lead Investors: Nexus Venture Partners, Blume Ventures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To secure initial capital for product development and market entry.
- Series A
- Amount Raised: USD 17,500,000
- Date: August 2021
- Lead Investors: Alpha Wave Incubation (AWI)
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To develop and market wearable health monitoring products including the CGM sensor and Ring.
- Angel Round
- Amount Raised: Not publicly disclosed
- Date: May 2022
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support ongoing growth and product expansion.
- Series B
- Amount Raised: USD 35,000,000 (USD 25,000,000 equity + USD 10,000,000 debt)
- Date: March 2024
- Lead Investors: Blume Ventures, Steadview Capital, Nexus Venture Partners
- Valuation at Round: Approximately USD 125,000,000
- Motivation Behind the Round: To expand manufacturing capabilities and conduct more in-depth health-tracking research.
- Venture Debt
- Amount Raised: INR 1,000,000,000 (~USD 11,300,000)
- Date: November 2025
- Lead Investors: Alteria Capital
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support market expansion, sports and research partnerships, and new software revenue streams.
- Series C (March 2026)
- Amount Raised: INR 4,000,000,000 (~USD 48,000,000)
- Date: March 2026
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand global wearables business and scale operations.
- Series C (September 2026)
- Amount Raised: INR 5,830,000,000 (~USD 60,000,000)
- Date: September 1, 2026
- Lead Investors: Qualcomm Ventures, with participation from Alpha Wave, Laboratory Corporation of America Holdings (Labcorp), Deepinder Goyal, Blume Ventures, Nexus Venture Partners, Steadview Capital, GGM Family Trust, Krypton Fund, InCred Wealth, and Joy Bhakat
- Valuation at Round: Approximately USD 363,000,000 post-money, about 65% above the prior Series B valuation
- Motivation Behind the Round: To expand the global wearables business and scale operations.
Total Amount Raised: At least USD 179,300,000 based on disclosed funding (Seed: $7.5M + Series A: $17.5M + Series B: $35M + Venture Debt Nov 2025: ~$11.3M + Series C Mar 2026: ~$48M + Series C Sep 2026: ~$60M; Angel Round amount undisclosed). As of September 2026, the company's latest disclosed round is its September 2026 Series C.
Current Valuation: Approximately USD 363,000,000
Key Investors
- Qualcomm Ventures
- Details: Qualcomm Ventures is the investment arm of Qualcomm. It led Ultrahuman's approximately $60 million Series C round in September 2026.
- Investment Focus Areas: Connectivity, semiconductors, artificial intelligence, digital health.
- Notable Investments: Ultrahuman.
- Alteria Capital
- Details: Alteria Capital is a venture debt fund that provides structured debt solutions to high-growth startups in India. They led the ₹100 crore venture debt round for Ultrahuman in November 2025.
- Investment Focus Areas: Technology, healthcare, consumer services.
- Notable Investments: Ultrahuman, Dunzo, Lendingkart.
- Steadview Capital
- Details: Steadview Capital is an investment firm focusing on long-term investments in public and private companies. They participated in Ultrahuman's Series A, co-led the Series B round, and joined the September 2026 Series C.
- Investment Focus Areas: Technology, healthcare, financial services.
- Notable Investments: Ultrahuman, Nykaa, Zomato.
- Blume Ventures
- Details: Blume Ventures is a venture capital firm investing in early-stage startups. They participated from the Seed round, co-led the Series B funding round in March 2024, and joined the September 2026 Series C.
- Investment Focus Areas: Technology, healthcare, consumer services.
- Notable Investments: Ultrahuman, Unacademy, Dunzo.
- Nexus Venture Partners
- Details: Nexus Venture Partners is a venture capital firm investing in early and growth-stage companies. They have participated in multiple Ultrahuman funding rounds from Seed through the September 2026 Series C.
- Investment Focus Areas: Technology, consumer services, healthcare.
- Notable Investments: Ultrahuman, Delhivery, Druva.
- Alpha Wave Incubation (AWI)
- Details: Alpha Wave Incubation is a global investment firm backed by DisruptAD and managed by Falcon Edge. They led Ultrahuman's Series A round in August 2021 and participated in subsequent rounds, including the September 2026 Series C.
- Investment Focus Areas: Technology, healthcare, consumer services.
- Notable Investments: Ultrahuman, Swiggy, Razorpay.
- Rainmatter Capital
- Details: Rainmatter Capital is the venture capital arm of Zerodha, India's largest retail stockbroker, focused on health, fintech, and climate sectors. They are among the disclosed equity investors in Ultrahuman.
- Investment Focus Areas: Fintech, health, climate.
- Notable Investments: Ultrahuman, Nirog Street, Smallcase.
What's Next for Ultrahuman?
Ultrahuman closed an approximately $60 million Series C round in September 2026 led by Qualcomm Ventures, at a post-money valuation of about $363 million, roughly 65% above its Series B valuation. The company has said the capital will go toward expanding its global wearables business and scaling operations.
The round also brought in Laboratory Corporation of America Holdings (Labcorp), Alpha Wave, Blume Ventures, Nexus Venture Partners, Steadview Capital, GGM Family Trust, Krypton Fund, InCred Wealth, and angel investors including Deepinder Goyal and Joy Bhakat.
Ultrahuman's product line spans the Ultrahuman Ring AIR, the Blood Vision blood testing service, and the M1 continuous glucose monitoring sensor. Competition from global players such as Levels Health and Oura, along with the accuracy requirements of health monitoring devices, remain factors as the company scales.
Use Clay to Get Funding Data
Sales professionals, take your strategy to the next level by leveraging Clay's platform to access comprehensive fundraising data on companies like Ultrahuman and gather other critical business insights.
Sign up for free to start making data-driven decisions and stay ahead in the competitive market.
